Analysen von Martin Wales

08.05.14 QIAGEN Neutral UBS AG
07.05.14 Fresenius Medical Care (FMC) St. Neutral UBS AG
27.03.14 Fresenius Medical Care (FMC) St. Neutral UBS AG
14.03.14 RHÖN-KLINIKUM Neutral UBS AG
07.03.14 Fresenius buy UBS AG
18.12.12 Fresenius buy UBS AG
07.12.12 bioMerieux SA neutral UBS AG
07.12.12 William Demant buy UBS AG
26.11.12 Fresenius buy UBS AG
14.11.12 Sonova neutral UBS AG
13.11.12 Fresenius buy UBS AG
09.11.12 RHÖN-KLINIKUM neutral UBS AG
08.11.12 DiaSorinAz. buy UBS AG
22.08.12 Straumann neutral UBS AG
21.08.12 Gedeon Richter Vegyeszeti Gyar Rt. buy UBS AG
17.08.12 Tecan (N) buy UBS AG
08.08.12 Valneva buy UBS AG
26.07.12 Lonza neutral UBS AG
26.07.12 Straumann neutral UBS AG
26.07.12 Elan neutral UBS AG
25.07.12 QIAGEN neutral UBS AG
04.07.12 Smith Nephew neutral UBS AG
20.06.12 Smith Nephew neutral UBS AG
12.06.12 Fresenius Medical Care (FMC) St. buy UBS AG
12.06.12 QIAGEN neutral UBS AG
28.05.12 Smith Nephew neutral UBS AG
08.05.12 Smith Nephew neutral UBS AG
26.04.12 QIAGEN neutral UBS AG
24.04.12 Shire buy UBS AG
15.03.12 William Demant neutral UBS AG
15.03.12 Coloplast A-S (B) sell UBS AG
13.02.12 Nobel Biocare neutral UBS AG
03.02.12 QIAGEN neutral UBS AG
30.11.11 QIAGEN neutral UBS AG
04.11.11 QIAGEN neutral UBS AG
25.10.11 Actelion buy UBS AG
28.07.11 QIAGEN neutral UBS AG
01.02.11 QIAGEN neutral UBS AG
28.01.11 QIAGEN neutral UBS AG
13.01.11 Elan neutral UBS AG
08.11.10 QIAGEN neutral UBS AG
12.08.10 QIAGEN neutral UBS AG